1.
Carvacrol Conjugated Zinc Oxide Nanoparticles as Prospective Agents against Clinically Isolated Carbapenem Resistant Acinetobacter Species. mfm [Internet]. 2022 Oct. 3 [cited 2026 May 31];33(9). Available from: https://medicalforummonthly.com/index.php/mfm/article/view/1042